ExploreWatchlistsPricing
  1. JP-listed companies
  2. Shionogi & Co.,Ltd.
  3. Financials
  4. Pretax margin (%)

Shionogi & Co.,Ltd. (4507)

Market cap
¥2.63T
P/E ratio
12x
Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPretax margin (%) YoY (%)
Mar 31, 202627.7-39.57%
Mar 31, 202545.8-5.27%
Mar 31, 202448.4-6.36%
Mar 31, 202351.6+37.06%
Mar 31, 202237.7-21.71%
Mar 31, 202148.1+1.69%
Mar 31, 202047.3+3.33%
Mar 31, 201945.8+13.81%
Mar 31, 201840.2+10.84%
Mar 31, 201736.3+11.56%
Mar 31, 201632.5+14.48%
Mar 31, 201528.4+32.34%
Mar 31, 201421.5+3.12%
Mar 31, 201320.8+20.77%
Mar 31, 201217.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat